Clinical Associations of Osteoporosis in BCR::ABL1 Negative Myeloproliferative Neoplasms
International Journal of Endocrinology · 2026-01 · 2026 (1)
DOI: 10.1155/ije/6041016 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Endocrinology, online erschienen am 16.05.2026. Verfasst von Mürüvvet Seda Aydin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Bone Marrow Transplantation, Ankara Bilkent City Hospital, Ankara, Turkey. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Aim Osteoporosis can be seen in some hematologic diseases, such as BCR::ABL1‐negative myeloproliferative neoplasms. The incidence and prevalence of osteoporosis and osteopenia in BCR::ABL1‐negative MPN are not very well known. Materials and Methods Patients diagnosed with one of the classical BCR::ABL1‐negative myeloproliferative neoplasms, such as essential thrombocythemia, polycythemia vera, and myelofibrosis, were included in the study. Due to the retrospective design, a matched control group was not available, and comparisons with the general population were made for contextual interpretation.
Results
Ninety‐four patients were included. Fifty‐eight (61.7%) patients had osteopenia, and 16 (17%) patients had osteoporosis according to femoral dual energy X‐ray absorptiometry (DXA) measurements. Fifty‐three (58.9%) patients had osteopenia, and 27 (30%) patients had osteoporosis according to lumbar DXA measurements. When both femur and lumbar DXA measurements were evaluated together, 67 (71.3%) patients had osteopenia and 31 (33%) patients had osteoporosis. In patients over 50 years of age, these frequencies were found to be 71.4% for osteopenia and 37.7% for osteoporosis. Osteopenia was significantly associated with female sex, cytoreduction, and longer disease duration ( p < 0.05). In the multivariate analysis, female sex was found to be an independent risk factor for osteopenia ( p = 0.009, OR: 3.70, 95% CI: 1.394–9.833). Osteoporosis was significantly associated with disease subtype, female sex, age, and no antiaggregant use ( p < 0.05). In the multivariate analysis, older age ( p = 0.044, OR: 1.04, 95% CI: 1.001–1.083) was found to be an independent risk factor for osteoporosis.
Conclusion
Patients with BCR::ABL1‐negative classical myeloproliferative neoplasms have a higher risk of osteopenia/osteoporosis compared to the general population. DXA measurements should be performed, especially in female patients and in patients of advanced age.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology and Bone Marrow Transplantation, Ankara Bilkent City Hospital, Ankara, Turkey.
- Department of Obstetrics and Gynecology, Mersin State Hospital, Mersin, Turkey, mersindevlethastanesi.gov.tr.
- Department of Anesthesiology and Reanimation, Ondokuz Mayıs University, Samsun, Turkey, omu.edu.tr.
- General Practitioner, Nallihan State Hospital, Ankara, Turkey.
ORCID-Profile: Mürüvvet Seda Aydin, Simten Dagdas, Mehmet Sezgin Pepeler, Gülten Korkmaz, Aysel Alper, Elif Açıkgöz, Tugce Nur Bektas, Merve Pamukçuoğlu, Funda Ceran, Gulsum Ozet
Zitieren
APA
Aydin, M. S., Dagdas, S., Pepeler, M. S., Korkmaz, G., Alper, A., Açıkgöz, E., Bektas, T. N., Pamukçuoğlu, M., Ceran, F., & Ozet, G. (2026). Clinical Associations of Osteoporosis in BCR::ABL1 Negative Myeloproliferative Neoplasms. International Journal of Endocrinology, 2026(1). https://doi.org/10.1155/ije/6041016
Vancouver
Aydin MS, Dagdas S, Pepeler MS, Korkmaz G, Alper A, Açıkgöz E, et al. Clinical Associations of Osteoporosis in BCR::ABL1 Negative Myeloproliferative Neoplasms. International Journal of Endocrinology. 2026;2026(1). doi:10.1155/ije/6041016
BibTeX
@article{Aydin2026,
author = {Aydin, Mürüvvet Seda and Dagdas, Simten and Pepeler, Mehmet Sezgin and Korkmaz, Gülten and Alper, Aysel and Açıkgöz, Elif and Bektas, Tugce Nur and Pamukçuoğlu, Merve and Ceran, Funda and Ozet, Gulsum},
title = {Clinical Associations of Osteoporosis in BCR::ABL1 Negative Myeloproliferative Neoplasms},
journal = {International Journal of Endocrinology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ije/6041016}
}
EUVIMED